Literature DB >> 7044545

Coagulative interventions during angiography.

J J Bookstein, K M Moser, C Hougie.   

Abstract

Incident to his routine diagnostic and interventional activities, the angiographer is becoming increasingly involved in the manipulation of blood clotting factors. Since the field of hemostasis generally extends beyond the sphere of conventional angiographic training, an analysis of selected angiographic aspects was undertaken. This paper reviews and summarizes the fundamentals of coagulation, and appropriate methods for manipulating coagulation during angiography, particularly via heparin and protamine sulfate. Basic aspects of platelet activity, and modifications produced by aspirin and dipyridamole, have been emphasized. Finally, the nature of the fibrinolytic system, and the current role of systemic and selective fibrinolytic therapy have been depicted.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7044545     DOI: 10.1007/bf02552105

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  45 in total

Review 1.  The role of the fibrinolytic system in thromboembolism.

Authors:  J G Vermylen; D A Chamone
Journal:  Prog Cardiovasc Dis       Date:  1979 Jan-Feb       Impact factor: 8.194

2.  Heparin dosage in extracorporeal circulation and its neutralization.

Authors:  D Nyman; N Thurnherr; F Duckert
Journal:  Thromb Diath Haemorrh       Date:  1975-02-28

Review 3.  Thrombolytic therapy is arterial thromboembolism.

Authors:  M Martin
Journal:  Prog Cardiovasc Dis       Date:  1979 Mar-Apr       Impact factor: 8.194

Review 4.  Heparin: new concepts relevant to clinical use.

Authors:  S Wessler; S N Gitel
Journal:  Blood       Date:  1979-04       Impact factor: 22.113

5.  Thrombolytic therapy: a comparison between urokinase and streptokinase. From a national cooperative study.

Authors:  W R Bell
Journal:  Semin Thromb Hemost       Date:  1975-07       Impact factor: 4.180

6.  Pharmocokinetics of heparin. Distribution and elimination.

Authors:  J W Estes; P F Poulin
Journal:  Thromb Diath Haemorrh       Date:  1975-02-28

7.  Heparin kinetics in venous thrombosis and pulmonary embolism.

Authors:  J Hirsh; W G van Aken; A S Gallus; C T Dollery; J F Cade; W L Yung
Journal:  Circulation       Date:  1976-04       Impact factor: 29.690

8.  Percutaneous transluminal angioplasty of the renal artery.

Authors:  D E Schwarten
Journal:  Cardiovasc Intervent Radiol       Date:  1980       Impact factor: 2.740

9.  Arterial thromboembolism in patients receiving systemic heparin therapy: a complication associated with heparin-induced thrombocytopenia.

Authors:  R A Baird; R Convery
Journal:  J Bone Joint Surg Am       Date:  1977-12       Impact factor: 5.284

10.  Bioequivalence of subcutaneous calcium and sodium heparins.

Authors:  F Bender; L Aronson; C Hougie; K Moser
Journal:  Clin Pharmacol Ther       Date:  1980-02       Impact factor: 6.875

View more
  1 in total

1.  Transcatheter thrombolysis in cancer patients.

Authors:  S Kudo; V P Chuang; S Wallace; S Mir; W Bechtel; C H Carrasco
Journal:  Cardiovasc Intervent Radiol       Date:  1985       Impact factor: 2.740

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.